EUCTR2006-005670-45-NL进行中（未招募）不适用
Population pharmacokinetics/pharmacodynamics of Propofol in morbidly obese patients - POP
St. Antonius hospital Nieuwegein0 个研究点开始时间: 2006年11月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Morbidly obese patients with a Body Mass Index > 40 undergoing laparoscopic banding or gastric bypass surgery, 18-60 year old.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Epilepsy, pregnancy, breastfeeding and known allergy for Propofol, egg lecithin or soy bean oil.
研究者
相似试验
已完成
不适用
Population pharmacokinetics/pharmacodynamics of Propofol in morbidly obese patientsmorbide obesitasmorbid obesityobeseNL-OMON31661anesthesiologie26
尚未招募
4 期
Childhood obesity and propofol infusioChildhood obesityAnaesthesiology - Other anaesthesiologyDiet and Nutrition - ObesityACTRN12611000451909Auckland City Hospital60
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
进行中（未招募）
1 期
Is treatment with the painkiller paracetamol safe in patients with spinal muscular atrophy and cerebral palsy?Spinal muscular atrophy type II (SMA II)Cerebral palsy (CP)EUCTR2018-002295-40-DKCopenhagen Neuromuscular Center24
进行中（未招募）
不适用
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20